Health

FDA Approves Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis

DailyTrendDailyTrend
Aug 13, 2025 - 04:00
 0  0
FDA Approves Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
BRIDGEWATER, N.J., Aug. 12, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Max Mobility / Permobil Announces Worldwide Expanded Recall and Removal of all SpeedControl Dials from the Market Due to Intermittent Cable Connection Concerns of the Dial with the SmartDrive MX2+ Motor. Users Must Use an Alternate Control Method for their SmartDrive MX2+ Power Assist Device.

Max Mobility / Permobil Announces Worldwide Expanded Re...

DailyTrend Aug 13, 2025  0  0

How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogaine

How Rick Perry Became a Fervent Advocate for the Psyche...

DailyTrend Aug 12, 2025  0  0

FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live): FDA Safety Communication

FDA Update on the Safety of Ixchiq (Chikungunya Vaccine...

DailyTrend Aug 7, 2025  0  0

Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps

Tandem Diabetes Care Issues Voluntary Medical Device Co...

DailyTrend Aug 13, 2025  0  0

FDA Approves Expanded Indication for Ajovy (fremanezumab-vfrm), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

FDA Approves Expanded Indication for Ajovy (fremanezuma...

DailyTrend Aug 7, 2025  0  0

Enmeshment: When a Relationship Is Too Close

DailyTrend Aug 8, 2025  0  0